Home Intert Group's Subsidiary Intert Pharmaceutical Signs Import Drug Procurement Agreement with AstraZeneca at CIIE

Intert Group's Subsidiary Intert Pharmaceutical Signs Import Drug Procurement Agreement with AstraZeneca at CIIE

Nov 06, 2022 23:48 CST Updated Nov 07, 14:18
AstraZeneca

Biopharmaceutical Manufacturer

INT Group Official WeChat, November 6th: On November 6th, the 5th CIIE Zhejiang Provincial Delegation Import Procurement Centralized Signing Ceremony was held in Shanghai. ZHEJIANG INT'L MEDICINE CO., LTD. successfully signed an import drug procurement project with AstraZeneca. ZHEJIANG INT'L MEDICINE CO., LTD. plans to introduce innovative drugs including cancer medicines, orphan drugs, targeted therapy drugs, and gene therapies.